Search results
AstraZeneca admits Covid-19 vaccine may cause blood clots in “very rare” cases
Pharmaceutical Technology via Yahoo Finance· 4 days agoAstraZeneca has been embroiled in a class action lawsuit for itsCovid-19 vaccine, admitting that the...
FLiRT – All You Need To Know About The Latest COVID-19 Variants
IFLScience· 5 days agoThere’s a family of new COVID-19 variants in town, and at least one of them looks set to begin...
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 5 days agoSyndrome, involving unusual and severe blood clotting events associated with low platelet counts,...
mRNA Vaccines: Not Just for COVID Soon?
Medscape· 4 days agoTo date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many ...
AstraZeneca admits in court documents that COVID-19 vaccine could cause serious rare side effect
Just the News· 4 days agoBritish pharmaceutical company AstraZeneca admitted in court documents for the first time that its ...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 4 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
AstraZeneca admits rare side effect of COVID-19 vaccine
Homenewshere.com· 2 days agoPharmaceutical company AstraZeneca acknowledged in U.K. court documents that its COVID-19 vaccine...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 3 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID< ...
What to Know About the 'FLiRT' Variants of COVID-19
Time Magazine· 6 days agoThe COVID-19 lull in the U.S. may soon come to an end, as a new family of SARS-CoV-2 variants—nicknamed “FLiRT” variants—begins to spread nationwide....
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 3 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...